Headquartered in Indonesia, HETZER MEDICAL INDONESIA Tbk, belongs to the Health Care sector. Filings by its managers are published through OJK / IDX. Over the twelve months to 22 October 2026, 46 filings were filed, from 1 insider.
No insider bought on the market over the period, while 1 insider filed 46 sales totalling €427k. At €45k, the sale published on 8 December 2025 by Jemmy Kurniawan is the largest of the period.
Filings reach the OJK / IDX feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
With 46 filings in twelve months, the company is more active than the median of 3 filings across the 290 companies we follow on the same exchange. Looking back to 2025, when coverage begins, insiders filed no purchases and 46 sales.
These figures are compiled from regulatory filings published by OJK / IDX. They describe what insiders did and are not a recommendation.
Headquarters: Indonesia
Source: Wikidata (CC0).
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 46 declarations
HETZER MEDICAL INDONESIA Tbk is a publicly traded company on the Indonesian Stock Exchange, specializing in the medical sector. It focuses on providing innovative medical solutions and products.